Skip to main content

Skitii

Category: AI in Healthcare

An AI-driven healthtech platform pioneering emotion-adaptive digital therapeutics to reduce physical and emotional suffering for cancer patients during chemotherapy. Skitii was founded in 2022. The company is led by Dr. Chirag Jain. Based in Mumbai, India. Team size: 11-50. Total funding raised: $505,000. Latest round: Seed. Key investors include ["IIT Mandi Catalyst","MSME (Government of India)","US-based Angel Investor"].

Founded
2022
Headquarters
Mumbai, India
Team size
11-50
Total funding
$505,000

Value proposition

Improves patient quality of life by providing real-time, personalized mitigation of chemotherapy-induced anxiety and pain through a closed-loop biometric feedback system.

Products and solutions

["Emotion-Adaptive Music Therapy (EAMT) Platform","Real-time AI Emotion Recognition Engine","Biometric Monitoring & Feedback System","Generative AI Therapeutic Music Creator"]

Unique value

Pioneers a 'closed-loop' therapeutic system that synchronizes generative AI music with real-time physiological and emotional data from the patient.

Target customer

Oncology patients (specifically breast cancer), oncology clinics, hospitals, and palliative care providers.

Industries served

["Healthtech","Oncology","Digital Therapeutics (DTx)","Mental Health & Wellness"]

Technology advantage

Integrates frontier technologies—real-time emotion recognition, biometric sensors, and generative AI—into a clinically validated platform led by a surgical consultant with 20+ years of experience.

How they differentiate

Skitii utilizes a 'closed-loop' therapeutic system that integrates real-time biometric sensors and AI-driven emotion recognition to adjust music therapy dynamically during chemotherapy sessions.

Main competitors

["MediMusic","LUCID","Spiritune"]

Key partnerships

["IIT Mandi Catalyst (Incubation & Pre-seed support)","MSME (Winner of MSME Hackathon 2.0 grants)","US-based Angel Investors","Mindful Gurukul (Parent entity focusing on neuropsychology and digital therapeutics)"]

Notable customers

["Oncology Clinics in Mumbai","Breast Cancer Support Groups"]

Major milestones

["Winner of the MSME Idea Hackathon 2.0 for AI innovation in healthcare.","Successful clinical validation of Emotion-Adaptive Music Therapy (EAMT) for breast cancer patients.","Incubated and received pre-seed support from IIT Mandi Catalyst.","Secured ₹4 crore in Seed funding from a US-based angel investor in January 2025."]

Growth metrics

Achieved a 150% valuation increase in the latest 2025 funding round following successful clinical validation.

Market positioning

Specialized Digital Therapeutics (DTx) provider for oncology supportive care.

Geographic focus

India, North America

Patents and IP

Proprietary algorithms for emotion identification and mindfulness interventions; patents developed and filed during the 2021-2022 proof-of-concept phase.

About Dr. Chirag Jain

Dr. Chirag Jain is a medical professional with over 20 years of clinical experience as a surgical consultant. He transitioned into healthtech as an AI innovator, focusing on neuroscience and emotional wellness. He is the founder and Executive Director of Mindful Gurukul, where he applies neuropsychology to digital therapeutics. He is also the author of 'What A Comeback!: A Unique Way to Understand the Science Of Resilience'.

Official website: